Clin Exp Vaccine Res.  2021 Jan;10(1):1-5. 10.7774/cevr.2021.10.1.1.

Polyvaccine: joining the links in the cascade of type 1 diabetes

Affiliations
  • 1Department of Pharmacology, Dr. D. Y. Patil Institute of Pharmaceutical Sciences and Research, Pune, India
  • 2Dr. D. Y. Patil Vidyapeeth, Pune, India
  • 3Serum Institute of India, Pune, India

Abstract

The incidence of type 1 diabetes mellitus (T1DM), an autoimmune disorder, has ascended considerably with around 98,200 and 15,900 incidents in children below 15 years of age, globally and in India, respectively. This is typically due to environmental changes leading to genetic modifications. Also, T1DM encompasses the presence of autoantigens and many other etiologies which can be targeted by proper immunization. In this paper, we consciously discuss and collate various candidate triggers of islet autoimmunity and other factors expected to promote progression of T1DM. This paper bridges all the mechanisms caused by these factors and linking them with each other. We have also highlighted on the novel corona virus as a trigger for T1DM. Finally, we suggest that an amalgamated model of polyvaccine can batter the condition by inducing protection against various triggers of T1DM.

Keyword

Type 1 diabetes mellitus; Viruses; Coronavirus; Cow’s milk; Hybrid insulin peptides; Vaccines
Full Text Links
  • CEVR
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr